Navigation Links
Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
Date:10/21/2009

th SGX acquisition - .03 Pro forma as if the ImClone acquisition was completed on January 1, 2008 - (.06) --- ---- Earnings per share (pro forma non-GAAP) $1.20 $.98 22% ----- ---- NM - not meaningful; numbers in the 2009 third quarter column do not add due to rounding. 
    Revenue Highlights - Reported
    -----------------------------

    (Dollars in millions)
                                        % Change                    % Change
                                          Over/                       Over/
                          Third Quarter  (Under)     Year-to-Date    (Under)
                          2009      2008  2008      2009       2008   2008
                          ----      ----  ----      ----       ----   ----
    Zyprexa           $1,223.0  $1,189.5    3%  $3,549.2   $3,549.5     0%
    Cymbalta( R )        790.2     716.4   10%   2,243.9    1,975.9    14%
    Humalog( R )         500.2     432.6   16%   1,428.2    1,277.8    12%
    Alimta( R )          461.9     313.9   47%   1,182.5      836.0    41%
    Cialis( R )          397.2     376.6    5%   1,119.6    1,075.7     4%
    Gemzar               331.8     440.2 (25)%   1,052.8    1,306.5  (19)%
    Evista               259.5     265.7  (2)%     767.7      806.6   (5)%
    Humulin( R )         260.4     271.6  (4)%     749.1      800.8   (6)%
    Forteo               213.1     192.7   11%     603.9      584.3     3%
    Strattera( R )       145.5     149.5  (3)%     447.2      432.7     3%
    Total Product
     Sales             5,385.5   5,092.4    6%  15,390.6   14,835.6     4%
    Collaboration and
     Other Revenue(1)    176.5     117.1   51%     511.2      331.9    54%
                         -----     -----           -----      -----
    Total Revenue(2)  $5,562.0  $5,209.5    7% $15,901.
'/>"/>
SOURCE  Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 

Related medicine technology :

1. Lilly Declares Fourth-Quarter Dividend
2. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
3. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
4. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
5. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
6. Study Showed Lillys GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients
7. Lilly Advances Second Alzheimers Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
8. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
9. Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research
10. FDA Issues a Complete Response Letter for Lillys Olanzapine LAI for Treatment of Schizophrenia in Adults
11. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology ... Sony SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting ... which will be held at the San ... Diego, California , from May 20 - 22.  ... second analytical system, incorporating commercial audio-visual technologies into new ...
(Date:5/17/2013)... , May 17, 2013 ... economics and outcomes research also   to   be ... SHPG ), the global specialty biopharmaceutical company, ... poster presentations at the American Psychiatric Association (APA) 166th ... May 18-22. The data being presented represent Shire,s ongoing ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... an investor meeting held today in New York, NY, ... an update on its Global businesses, including a detailed ... its Global Generics and Global Brands businesses, and an ... with the meeting, the Company provided its preliminary 2011 ...
... Inc. (Nasdaq: VVUS ) today announced that it ... (FDA) for the New Drug Application (NDA) for QNEXA®, an ... on January 19th at the FDA,s offices in Maryland and ... management and consultants.  At this meeting the FDA requested that ...
Cached Medicine Technology:Watson Presents Outlook for Continued Long Term Growth 2Watson Presents Outlook for Continued Long Term Growth 3Watson Presents Outlook for Continued Long Term Growth 4Watson Presents Outlook for Continued Long Term Growth 5Watson Presents Outlook for Continued Long Term Growth 6Watson Presents Outlook for Continued Long Term Growth 7Watson Presents Outlook for Continued Long Term Growth 8VIVUS Provides Regulatory Update on QNEXA NDA 2VIVUS Provides Regulatory Update on QNEXA NDA 3
(Date:5/19/2013)... In partnership with the medical practice online marketing company, JD ... SEO website for dentists. The purpose of the site is ... http://www.e-dentists.com/ , A perk to the service is that ... results. Dentists can request the keywords they want included in ... Surge, LLC rank high for competitive keywords. Dentists can rely ...
(Date:5/19/2013)... 19, 2013 According to a ... and Forecast (2013 – 2018): By Applications (Healthcare ... Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) And ... sensor market was $8.00 billion in 2012 and ... at an estimated CAGR of 3.84% from 2013 ...
(Date:5/19/2013)... The Pradaxa lawyers at Bernstein Liebhard ... convened for hundreds of Pradaxa bleeding lawsuits ... U.S. District Court, Southern District of Illinois. According ... 14th, the Conference addressed the status of depositions and ... Conference that Defendants submitted a list of early trial ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Vegas Hotel ... is proud to announce the launch it's all new ... the MGM Grand on 5/19/2013. Consumers traveling to Las ... special pricing available on VegasHotelEscapes.com's website. Travelers will be ... beat any competitors price. , Vegas Hotel Escapes specializes ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Beginning Wednesday, May ... Valley Blood Center (RRVBC) will feature “Hot Dog Wednesdays" and ... RRVBC will provide hot dogs and all the fixin's ... slushies each day throughout the summer. “Donors are our lifeline. ... a stable and adequate blood supply. This is a ...
Breaking Medicine News(10 mins):Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2
... polyphenol compounds affect areas involved with learning and memory , , ... the cognitive problems that come with obstructive sleep apnea (OSA), ... appear to negate the increased oxidative stress that affects brain ... with OSA, reports the study, published in the second issue ...
... than ten million Americans whove received drug-eluting stents to ... according to new research from the University of Pennsylvania ... large follow-up studies to show a clear, lifesaving benefit ... be published in the May 27 issue of the ...
... DALLAS, May 22 Parks Associates and ... host a free pre-show session,at CONNECTIONS(TM) on ... a,non-profit, open-industry coalition of the finest healthcare ... improve the quality of,personal healthcare by establishing ...
... Effects Significant for Adult Acne Sufferers, LOS ANGELES, ... a teenage "rite of passage," results from a groundbreaking,national ... that also,commonly affects adults. The survey finds that acne ... professional, academic, physical and,social -- and a basic lack ...
... Brewer Announces Fundraiser As Part Of Its Summer-Long Harley-Davidson ... 105th Anniversary Celebration Promotion, MILWAUKEE, ... the Muscular Dystrophy Association (MDA) for every Miller Lite,bottle cap ... brand,s,"Better. Bolder. Summer" promotion. Miller Lite, the "ultimate light beer,",is ...
... tumor-suppressor p53 could just as easily shelter a mutant version ... rather than die, according to research by scientists at The ... the current issue of the journal Genes and Development. ... p53, we need to make sure we first know what ...
Cached Medicine News:Health News:Green Tea May Help Brain Cope With Sleep Disorders 2Health News:More patients with drug-coated cardiac stents survive, avoid costly follow-up procedures 2Health News:Continua Health Alliance Provides Insight Into Next Generation of Digital Health at CONNECTIONS(TM) 2Health News:Acne - Not Just a Teen Issue 2Health News:Acne - Not Just a Teen Issue 3Health News:Acne - Not Just a Teen Issue 4Health News:Acne - Not Just a Teen Issue 5Health News:Acne - Not Just a Teen Issue 6Health News:Miller Lite Bottle Caps Equal Cash for MDA This Summer 2Health News:Miller Lite Bottle Caps Equal Cash for MDA This Summer 3Health News:Stabilizing cancer-fighting p53 can also shield a metastasis-promoter 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: